DE69431624T2 - Impfstoff gegen mittelohrentzündung - Google Patents

Impfstoff gegen mittelohrentzündung

Info

Publication number
DE69431624T2
DE69431624T2 DE69431624T DE69431624T DE69431624T2 DE 69431624 T2 DE69431624 T2 DE 69431624T2 DE 69431624 T DE69431624 T DE 69431624T DE 69431624 T DE69431624 T DE 69431624T DE 69431624 T2 DE69431624 T2 DE 69431624T2
Authority
DE
Germany
Prior art keywords
fimbrin
ignition
vaccine against
dna coding
against medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69431624T
Other languages
English (en)
Other versions
DE69431624D1 (de
Inventor
Pappachan E Kolattukudy
Lauren O Bakaletz
Tatiana Sirakova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Publication of DE69431624D1 publication Critical patent/DE69431624D1/de
Application granted granted Critical
Publication of DE69431624T2 publication Critical patent/DE69431624T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
DE69431624T 1993-05-18 1994-05-12 Impfstoff gegen mittelohrentzündung Expired - Fee Related DE69431624T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6544293A 1993-05-18 1993-05-18
PCT/US1994/005477 WO1994026304A1 (en) 1993-05-18 1994-05-12 Otitis media vaccine

Publications (2)

Publication Number Publication Date
DE69431624D1 DE69431624D1 (de) 2002-12-05
DE69431624T2 true DE69431624T2 (de) 2003-07-10

Family

ID=22062752

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69431624T Expired - Fee Related DE69431624T2 (de) 1993-05-18 1994-05-12 Impfstoff gegen mittelohrentzündung

Country Status (9)

Country Link
US (3) US5766608A (de)
EP (2) EP0699076B1 (de)
JP (1) JP3429313B2 (de)
AT (1) ATE226831T1 (de)
DE (1) DE69431624T2 (de)
DK (1) DK0699076T3 (de)
ES (1) ES2185658T3 (de)
PT (1) PT699076E (de)
WO (1) WO1994026304A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2185658T3 (es) 1993-05-18 2003-05-01 Univ Ohio State Res Found Vacuna para la otitis media.
JPH09500013A (ja) * 1993-06-01 1997-01-07 ライフ・テクノロジーズ・インコーポレイテッド カチオン性脂質による遺伝子免疫
US5770213A (en) 1994-05-05 1998-06-23 American Cyanamid Company Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection
US5843464A (en) 1995-06-02 1998-12-01 The Ohio State University Synthetic chimeric fimbrin peptides
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
AU772847B2 (en) * 1998-11-12 2004-05-06 Invitrogen Corporation Transfection reagents
SI1162999T1 (sl) 1999-03-19 2007-04-30 Glaxosmithkline Biolog Sa Vakcina proti Streptococcus pneumoniae
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0117762D0 (en) * 2001-07-20 2001-09-12 Glaxosmithkline Biolog Sa Novel compounds
ES2537737T3 (es) 2002-08-02 2015-06-11 Glaxosmithkline Biologicals S.A. Composiciones de vacuna que comprenden lipooligosacáridos de inmunotipo L2 y/o L3 de Neisseria meningitidis de IgtB
ATE352316T1 (de) 2002-11-01 2007-02-15 Glaxosmithkline Biolog Sa Immunogene zusammensetzung
US8574596B2 (en) 2003-10-02 2013-11-05 Glaxosmithkline Biologicals, S.A. Pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
EP2298794A3 (de) * 2005-07-08 2011-04-06 Nationwide Children's Hospital, Inc. Chimärer Impfstoff gegen Haemophilus Influenzae induzierte Krankheiten
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
ES2707499T3 (es) 2005-12-22 2019-04-03 Glaxosmithkline Biologicals Sa Vacuna de conjugado de polisacárido neumocócico
KR101737464B1 (ko) 2006-01-17 2017-05-18 아르네 포르스그렌 아베 표면 노출된 헤모필루스 인플루엔자 단백질 （단백질 Ｅ ― ｐＥ）
RS54349B1 (en) 2007-06-26 2016-02-29 Glaxosmithkline Biologicals S.A. VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES
EP2250286A1 (de) * 2008-02-15 2010-11-17 Life Technologies Corporation Verfahren und zusammensetzungen zum scheren von polymeren mittels ultraschallbehandlung
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
US20130011429A1 (en) 2010-03-10 2013-01-10 Jan Poolman Immunogenic composition
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
EP2717909B1 (de) 2011-06-04 2017-12-06 Rochester General Hospital Research Institute Zusammensetzungen und verfahren in zusammenhang mit p6 von haemophilus influenzae
CA2904388C (en) 2013-03-08 2023-09-26 Research Institute At Nationwide Children's Hospital Transcutaneous dosage formulation
EP3169310A1 (de) 2014-07-15 2017-05-24 Life Technologies Corporation Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
IE20190084A3 (en) 2017-05-30 2023-07-19 Glaxosmithkline Biologicals Sa Novel methods for manufacturing an adjuvant
EP3717001A1 (de) 2017-12-01 2020-10-07 GlaxoSmithKline Biologicals S.A. Saponinreinigung
MX2021001479A (es) 2018-08-07 2021-04-28 Glaxosmithkline Biologicals Sa Novedosos procesos y vacunas.
EP3886901A1 (de) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Verfahren zur herstellung eines adjuvans
CA3142300A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
US5110908A (en) * 1986-12-31 1992-05-05 Praxis Biologics, Inc. Haemophilus influenzae peptides and proteins
ES2185658T3 (es) 1993-05-18 2003-05-01 Univ Ohio State Res Found Vacuna para la otitis media.

Also Published As

Publication number Publication date
ATE226831T1 (de) 2002-11-15
WO1994026304A1 (en) 1994-11-24
US5766608A (en) 1998-06-16
JPH09500104A (ja) 1997-01-07
EP1300156A3 (de) 2003-05-07
EP0699076A4 (de) 1999-09-08
DK0699076T3 (da) 2003-03-03
US6562349B1 (en) 2003-05-13
JP3429313B2 (ja) 2003-07-22
EP0699076A1 (de) 1996-03-06
ES2185658T3 (es) 2003-05-01
DE69431624D1 (de) 2002-12-05
EP0699076B1 (de) 2002-10-30
US6030626A (en) 2000-02-29
PT699076E (pt) 2003-03-31
EP1300156A2 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
DE69431624T2 (de) Impfstoff gegen mittelohrentzündung
IL114809A0 (en) Mutant br96 antibodies
NO953033L (no) Stabile baktericid/permeabilitetsökende proteinprodukter og farmasöytiske preparater inneholdende disse
DE3770915D1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
HUP9801638A2 (hu) Kevésbé adszorbeálódó és jobban hidrolizáló proteáz K variánsok
DE69217144D1 (de) Regulator-DNA zur Gen-Expression
DE69129604D1 (de) Mutierte beta-Lactamacylasegene
ATE255165T1 (de) Rekombinantes mersacidin und verfahren zu seiner herstellung
AU8258591A (en) Human mk gene and protein sequence
AUPP627498A0 (en) Novel peptides - i
EP1251176A3 (de) Expressionssysteme, die selbstspaltende Fusionsproteine verwenden sowie ein reduzierendes Polypeptid
WO2001044289A3 (en) Modified leukotoxin gene and protein
AU4568496A (en) Acarbose biosynthesis genes from Actinoplanes sp., process for the isolation thereof and the use thereof
WO2001066759A3 (en) 26886, a novel carnitine acyltransferase family member and uses therefor
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
ATE107694T1 (de) Für a.nidulans-isopenicillin-n-synthetase codierende dns, deren verwendung und dafür codierende vektoren.
WO2002026817A3 (en) 33521, a human guanine nucleotide exchange family member and uses thereof
EP1158052A4 (de) Beta-primeverosidase gen
TH10372EX (th) จีนเซฟาโลสปอรินแอเซทิลไฮโดรเลสและโปรตีนที่ประมวลรหัสไว้ในจีนดังกล่าว
WO2001096545A3 (en) 50090, a human hydratase and uses thereof
WO2002062962A3 (en) 60491, a novel human acyltransferase family member and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee